[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NVO
Eli Lilly's new drug Retatrutide shows significant weight loss, potentially impacting Novo Nordisk's market share. Meanwhile, a new bill targets compounded GLP-1 drugs, which could benefit Novo Nordisk.
About NVO
Novo Nordisk is a pharmaceutical company specializing in diabetes and obesity treatments.
Insights
- nvo sentiment is up XXXXX% from the previous week.
- nvo engagements is up XXXXX% from the previous week.
Engagements: XXXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX +29%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXXXX +38%
X Year: XXXXXXXXXXX +143%
1-Year High: XXXXXXXXX on 2025-06-23
1-Year Low: XX on 2025-12-04
Engagements by network (24h): News: XXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXXX YouTube: XXXXXXX
Mentions: XXXXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XXXX%
X Months: XXXXXX +57%
X Year: XXXXXX +96%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-12-04
Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning NVO in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX +4.20%
X Month: XXXXX -XXXX%
X Months: XXXXXX +91%
X Year: XXXXXX +100%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-12-04
The most influential creators that mention NVO in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TheLongInvest | X | XXXXXXX | X | XXXXXXX |
| @firssj | X | XXXXXXXXX | X | XXXXXX |
| @SiemprePulpo | X | XXXXX | X | XXXXXX |
| @Nebraskangooner | X | XXXXXXX | X | XXXXXX |
| @himshouse | X | XXXXXX | X | XXXXXX |
| @MMatters22596 | X | XXXXXX | X | XXXXXX |
| @TacticzH | X | XXXXXX | X | XXXXXX |
| @investseekers | X | XXXXX | XX | XXXXXX |
| @pdicarlotrader | X | XXXXXX | X | XXXXXX |
| @DeepIceValue | XX | XXXXXX | XX | XXXXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +11%
X Month: XX% +10%
X Months: XX% +6%
X Year: XX% +9%
1-Year High: XXX% on 2025-10-31
1-Year Low: XX% on 2025-12-06
Most Supportive Themes:
- Market Dominance in Diabetes and Obesity: (35%) Novo Nordisk's strong position in the diabetes and obesity market, with analysts predicting significant sales growth and a favorable valuation compared to competitors.
- Analyst Upgrades and Doctor Recommendations: (25%) HSBC upgrades Novo Nordisk to Buy, citing an undervalued pipeline and a stronger focus on direct-to-consumer channels, while European doctors recommend Wegovy/Ozempic as first-line treatments for obesity.
- Strategic Expansion and Partnerships: (15%) Novo Nordisk's strategic moves, such as partnerships with telehealth platforms and expansion into new markets like India, are seen as positive steps to maintain market share and drive future growth.
Most Critical Themes:
- Restructuring and Job Cuts Concerns: (20%) The company's restructuring plan, including significant job cuts, raises concerns about morale, leadership, and the ability to maintain growth in a competitive market.
- Increased Competition and Pricing Pressure: (5%) Increased competition from Eli Lilly (LLY) and generic copycats, along with supply chain issues and political pressure on drug pricing, pose challenges to Novo Nordisk's market share and profitability.
Top NVO News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Novo Nordisk A/S (NVO): A Bull Case Theory"
News Link @YahooFinance 2025-12-04T18:34Z 228.6M followers, 5279 engagements
"Here's Why Novo Nordisk Just Paid $XXX Billion For Zaltenibart (NYSE:NVO) Seeking Alpha"
News Link @SeekingAlpha 2025-12-03T08:51Z 228.6M followers, 4229 engagements
Top NVO Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"I am long $NVO and I captured the whole $AMD move although I exited at $XXX for +180% gains in X months (many in group did too) My expectations for $NVO are much lower and I think a double in X years is a sensible base expectation"
X Link @SixSigmaCapital 2025-12-11T21:31Z 28.3K followers, 5242 engagements
"$PTGX PN-477 is a really interesting peptide development candidate. If M&A: $JNJ would not only save the full control of Icotrokinra - they could also make a step into the #obesity market. $LLY $NVO $VKTX"
X Link @doepke_michel 2025-12-11T21:19Z 5934 followers, 17.9K engagements
"$nvo looks like this one is finally ready for a move back over $XX The market has made a big mistake letting this name get this cheap. Will you be one of the fortunate ones to capitalize on it"
X Link @shortthevix2 2025-12-11T20:40Z 3061 followers, 1159 engagements
"$NVO and $LLY are engaged in an effectiveness arms race It could be that the industry is past the beginning stages where all GLP1s had strong demand as patients and doctors were happy that finally there was an effective obesity treatment. We could be entering a cyclical stage where a one player releases an updated drug that has the highest effectiveness leading the other to underperform for a year or two until it releases a more effective drug"
X Link @TheRayMyers 2025-12-11T20:24Z 15.8K followers, 2213 engagements